The Dexmethylphenidate XR Shortage: Where Things Stand in 2026

If you take Dexmethylphenidate XR (brand name Focalin XR) for ADHD, you've probably dealt with months — or even years — of difficulty finding your medication. The nationwide stimulant shortage that began in late 2022 has been one of the longest and most disruptive drug shortages in recent memory.

Here's the latest on what's happening, what it costs, and how to get your prescription filled.

Is Dexmethylphenidate XR Still in Shortage?

Yes. As of early 2026, Dexmethylphenidate XR remains on the ASHP (American Society of Health-System Pharmacists) drug shortage list. Multiple strengths from multiple manufacturers are on back order:

• Par Pharmaceutical has generic Dexmethylphenidate XR 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 35 mg, and 40 mg on back order with no estimated release date
• Sandoz has experienced intermittent supply issues with brand-name Focalin XR
• Other generic manufacturers have had varying availability depending on strength

The bottom line: supply is better than it was at the peak of the crisis in 2023, but many patients are still struggling to find their specific dose.

Why Is Dexmethylphenidate XR Still Hard to Find?

The shortage comes down to three main factors that have persisted for years:

DEA Production Quotas

The DEA sets annual limits on how much of each Schedule II controlled substance can be manufactured. These quotas haven't kept pace with growing demand. In 2024, the DEA began transitioning to a semi-annual quota system, but the changeover caused additional disruptions. In late 2025, the DEA increased production quotas for several ADHD medications, which should help — but it takes time for increased quotas to translate into filled prescriptions at your local pharmacy.

Manufacturing Challenges

Several manufacturers have faced production delays, quality control issues, and raw material constraints. When one manufacturer falls behind, the others can't always compensate because they're also operating near their quota limits.

Surging Demand

ADHD diagnoses have climbed significantly, especially among adults. The rise of telehealth has made it easier to get evaluated, leading to more prescriptions. More demand against a constrained supply means ongoing shortages.

For a deeper look, see our article on why Dexmethylphenidate XR is so hard to find.

How Much Does Dexmethylphenidate XR Cost in 2026?

Cost depends heavily on whether you have insurance and which version you're getting:

• Brand-name Focalin XR: $250 to $490/month for 30 capsules at retail price
• Generic Dexmethylphenidate ER: $40 to $150/month with a discount coupon from GoodRx, SingleCare, or similar services
• With insurance: Copays for the generic typically range from $10 to $50, depending on your plan's formulary tier

If cost is a barrier, check out our full guide on how to save money on Dexmethylphenidate XR, which covers coupons, manufacturer savings programs, and patient assistance.

Are There New Options in 2026?

While no brand-new Dexmethylphenidate XR products have launched, there are some developments worth noting:

• Increased DEA quotas announced in late 2025 should gradually improve supply throughout 2026
• Additional generic manufacturers have entered or are entering the market, which should increase the total supply of Dexmethylphenidate ER capsules
• Telehealth prescribing remains available for ADHD medications, making it easier to get appointments with prescribers who can adjust your treatment plan if your current medication is unavailable

If Dexmethylphenidate XR remains hard to find for you, your doctor may recommend trying an alternative ADHD medication that may be more readily available.

How to Find Dexmethylphenidate XR in Stock

Here are the most effective strategies:

1. Use Medfinder to check real-time pharmacy availability in your area
2. Try independent pharmacies — they often have more flexibility with ordering
3. Start looking early — begin your search 7-10 days before your refill is due
4. Ask your pharmacist to place a back order or put you on a notification list
5. Widen your search — pharmacies in smaller towns may have stock when urban ones don't

For a detailed walkthrough, read our guide on how to find Dexmethylphenidate XR in stock near you.

Final Thoughts

The Dexmethylphenidate XR shortage has been going on for over three years, and while there are signs of improvement — increased DEA quotas, new generic entrants — the reality is that many patients are still dealing with spotty availability in 2026.

Stay proactive: use Medfinder, work closely with your doctor and pharmacist, and know your alternatives. If you need help finding a doctor who prescribes Dexmethylphenidate XR, we have a guide for that too.